PharmEasy IPO News
PharmEasy has filed the 'Draft Red Herring Prospectus.'
CAIT wrote a letter to SEBI to halt PharmEasy’s IPO.
The organisation cited a Delhi High Court order passed in 2018.
API Holdings Ltd, PharmEasy`s parent, may also consider a further issue of equity shares via a private placement of up to 12.50 billion rupees, the company said in its draft red herring prospectus.
Loading...